Wordt geladen...
Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review
Treatment with immune checkpoint inhibitors has shown efficacy against a variety of cancer types. The effects of nivolumab and pembrolizumab on lung cancer have been reported, and further therapeutic advances are ongoing. The side effects of immune checkpoint inhibitors are very different from those...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409155/ https://ncbi.nlm.nih.gov/pubmed/32610470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072033 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|